Private company
Silk Road Medical Inc
American surgical and medical instruments and apparatus company.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
71.7%Gross margin3
-33.5%Operating margin3
-31.5%Net margin3
27.8%Revenue growth, 20233
-36.9%Return on equity3
0.50×Debt to equity3
-$33.5MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue21¢$50.0M
- Research and development17¢$41.3M
- Selling, general and admin60¢$145.0M
- Interest3¢$6.9M
- Income tax0¢$43.0K
Out of $177.1M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $34.6M4 | $63.4M5 | $75.2M6 | $101.5M3 | $138.6M3 | $177.1M3 | |
| Cost of revenue | $10.9M4 | $15.9M5 | $21.3M6 | $25.4M3 | $37.9M3 | $50.0M3 | |
| Gross profit | $23.7M4 | $47.4M5 | $53.9M6 | $76.0M3 | $100.8M3 | $127.1M3 | |
| Research and development | $10.3M4 | $12.3M5 | $21.3M6 | $27.1M3 | $36.4M3 | $41.3M3 | |
| Selling, general and admin | $34.8M4 | $63.2M5 | $75.5M6 | $96.4M3 | $116.3M3 | $145.0M3 | |
| Operating income | -$21.4M4 | -$28.1M5 | -$42.9M6 | -$47.5M3 | -$52.0M3 | -$59.3M3 | |
| Interest | $4.4M4 | $5.0M5 | $4.4M6 | $2.5M3 | $5.1M3 | $6.9M3 | |
| Income tax | $14.0K4 | $8.0K5 | $11.0K6 | $20.0K3 | $29.0K3 | $43.0K3 | |
| Net income | -$37.6M4 | -$52.4M5 | -$47.4M6 | -$49.8M3 | -$55.0M3 | -$55.7M3 | |
| Earnings per share | -$1.446 | -$1.443 | -$1.543 | -$1.443 | |||
| Earnings per share (diluted) | -$1.446 | -$1.443 | -$1.543 | -$1.443 |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $33.8M4 | $25.0M9 | $39.2M4 | $69.5M5 | $110.2M6 | $55.4M3 | $20.2M3 |
| Current assets | $38.5M9 | $112.5M4 | $173.3M5 | $143.3M6 | $254.9M3 | $240.8M3 | |
| Total assets | $42.7M9 | $137.4M4 | $179.3M5 | $156.6M6 | $269.7M3 | $265.3M3 | |
| Current liabilities | $10.7M9 | $16.9M4 | $19.6M5 | $26.1M6 | $24.5M3 | $30.3M3 | |
| Long-term debt | $44.2M9 | $44.9M4 | $48.5M5 | $44.8M6 | $74.6M3 | $75.6M3 | |
| Total liabilities | $72.1M9 | $65.5M4 | $71.8M5 | $77.4M6 | $105.8M3 | $114.2M3 | |
| Shareholders’ equity | -$98.6M4 | -$134.6M9 | $71.9M4 | $107.5M5 | $79.2M6 | $163.9M3 | $151.2M3 |
| Shares outstanding | 1.1M shares9 | 31.3M shares4 | 34.2M shares5 | 35.0M shares6 | 38.4M shares3 | 39.2M shares3 |
Leadership
Who has led Silk Road Medical Inc, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
20202025
- Chief executive officerChas McKhann Nov 3, 2023 to Sep 18, 202410
- Chief executive officerErica J. Rogers Apr 3, 2019 to Sep 29, 202311
- PresidentErica J. Rogers Apr 3, 2019 to Sep 29, 202311
- Chief financial officerLucas W. Buchanan Apr 3, 2019 to Sep 18, 202412
- Chief operating officerLucas W. Buchanan Oct 16, 2020 to Sep 18, 202413
Board members and other officers (15)
- CAO and VP, FinanceMarie L. Jones Mar 20, 2023 to Sep 18, 202414
- EVP Global Sales & MarketingAndrew S. Davis Apr 3, 2019 to Sep 18, 202415
- Board memberChas McKhann Nov 3, 2023 to Sep 18, 202410
- Board memberTanisha Carino Jul 26, 2021 to Sep 18, 202416
- Board memberRick D. Anderson Oct 5, 2020 to Sep 18, 202417
- Board memberKevin J. Ballinger Dec 4, 2020 to Sep 18, 202418
- Board memberAmr Kronfol Apr 3, 2019 to Jun 7, 201919
- Board memberDonald Zurbay Apr 3, 2019 to Sep 18, 202420
- Board memberElizabeth H. Weatherman Apr 3, 2019 to Sep 18, 202421
- Board memberErica J. Rogers Apr 3, 2019 to Sep 29, 202311
- Board memberJack W. Lasersohn Apr 3, 2019 to Sep 18, 202422
- Board memberRobert Mittendorff Apr 3, 2019 to Jun 10, 201923
- Board memberRuoxi Chen Apr 3, 2019 to Jul 13, 202024
- Board memberTony M. Chou Apr 3, 2019 to Sep 18, 202425
- General counselKevin M. Klemz Sep 2, 2022 to Sep 18, 202426
Timeline
Filings
235 filings to the SEC since October 2021: 3 annual reports, 9 quarterly reports, 28 major events, 125 insider forms, 17 large holders, 53 other. The latest 20:
- Sep 27, 202415-12G EDGAR
- Sep 23, 2024EFFECT EDGAR
- Sep 19, 2024SC 13D/A EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 18, 20244 EDGAR
- Sep 17, 2024S-8 POS EDGAR
- Sep 17, 2024S-8 POS EDGAR
- Sep 17, 2024S-8 POS EDGAR
- Sep 17, 2024S-8 POS EDGAR
The 235 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 17 such filings since October 2021, the latest 10:
- Sep 19, 2024SC 13D/A
- Aug 12, 2024SC 13D
- Jul 10, 2024SC 13G/A
- Jul 1, 2024SC 13G/A
- Feb 13, 2024SC 13G/A
- Feb 9, 2024SC 13G/A
- Oct 20, 2023SC 13G
- May 10, 2023SC 13G/A
- Feb 13, 2023SC 13G/A
- Feb 10, 2023SC 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARMarie L. Jones, CAO and VP, Finance
- 15
- 16SEC EDGARTanisha Carino, Board member
- 17SEC EDGARRick D. Anderson, Board member
- 18SEC EDGARKevin J. Ballinger, Board member
- 19SEC EDGARAmr Kronfol, Board member
- 20SEC EDGARDonald Zurbay, Board member
- 21
- 22SEC EDGARJack W. Lasersohn, Board member
- 23SEC EDGARRobert Mittendorff, Board member
- 24SEC EDGARRuoxi Chen, Board member
- 25SEC EDGARTony M. Chou, Board member
- 26SEC EDGARKevin M. Klemz, General counsel
- 27